OPC-67683, a Nitro-Dihydro-Imidazooxazole Derivative with Promising Action against Tuberculosis In Vitro and In Mice
Makoto Matsumoto(Tottori University Hospital), Makoto Komatsu(Otsuka (Japan)), Masanori Kawasaki(Otsuka (Japan)), Hidetsugu Tsubouchi(Otsuka (Japan)), Hiroyuki Hashizume(Otsuka (Japan)), Tatsuo Tomishige(Otsuka (Japan)), Yoshihiko Shimokawa(Otsuka (Japan)), Hirofumi Sasaki(Otsuka (Japan))
Cited by 745
Related Papers
A Toll-like receptor recognizes bacterial DNA
|Nature|2000|6.4k
HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY
|The Lancet|1986|2.4k
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
|Immunity|1998|2k
Essential role of Stat6 in IL-4 signalling
|Nature|1996|1.6k
Targeted disruption of the mouse <i>Stat3</i> gene leads to early embryonic lethality
|Proceedings of the National Academy of Sciences|1997|1.3k